Sheller PC’s $70 Million Risperdal win hits #1 on the Top 50 Verdicts in Pennsylvania in 2016. In the case A.Y., Pro Ami v. Janssen Pharmaceuticals, Inc.,
On October 7, 2017, Stephen and Sandra Sheller will be honored by the National Liberty Museum as their 2017 “Heroes of Liberty” at the Glass
Here’s an update on our earlier post about IVC heart filter injuries. Sheller, P.C. medical device attorneys continue to investigate injuries and deaths related to
Long term data about the Essure contraceptive device suggest that it may pose risks of serious complications. Essure is a birth control device that consists of two
Sheller, P.C. attorneys are investigating the newer class of diabetes drugs following FDA warnings. ABOUT THE DRUGS Invokana (Invokamet) is a relatively new SGLT2 inhibitor
[pdf-embedder url=”/wp-content/uploads/2015/05/1212-Philadelphia-Life_Sheller_profile_FINAL.pdf”]
The attorneys at Sheller P.C. have been recognized again this year as SuperLawyers. For the twelfth consecutive year, founder Stephen A. Sheller has been selected by the organization
The Wall Street Journal 2013-07-26 The Wall Street Journal today published a front page story on the Department of Justice investigation into fraud in physician-owned
Pharmalot.com, Pharmaceutical Industry News 2013-07-11 In an unusual tactic, an attorney is prodding the FDA to seek documents that purportedly detail side effects caused by
The Philadelphia Inquirer & “Fierce Pharma” 2013-07-10 The U.S. Food and Drug Administration is dragging its feet in addressing concerns that Johnson & Johnson’s antipsychotic
The American Law Journal 2013-06-16 Attorney Stephen Sheller sparred with pharmaceutical defense attorney Hope Freiwald of Dechert law firm on the television program The American
2013-06-25 In a case involving a Philadelphia company, a divided U.S. Supreme Court ruled Monday that federal pharmaceutical laws preempt a person’s ability to sue
Sheller, P.C.
1515 Market Street, Suite 1100
Philadelphia, PA 19102
Phone: 215-790-7300
info@sheller.com
